ALS CLINICAL RESEARCH LEARNING INSTITUTE Trademark

Trademark Overview

On Friday, January 17, 2020, a trademark application was filed for ALS CLINICAL RESEARCH LEARNING INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the ALS CLINICAL RESEARCH LEARNING INSTITUTE trademark a serial number of 88763677. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, January 16, 2026. This trademark is owned by Northeast Amyotrophic Lateral Sclerosis Consortium. The ALS CLINICAL RESEARCH LEARNING INSTITUTE trademark is filed in the Education & Entertainment Services category with the following description:

educational services, namely, providing seminars, workshops and classes in the field of clinical research and treatments to benefit people with Amyotrophic Lateral Sclerosis (ALS) and/or motor neuron disease
als clinical research learning institute

General Information

Serial Number88763677
Word MarkALS CLINICAL RESEARCH LEARNING INSTITUTE
Filing DateFriday, January 17, 2020
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, January 16, 2026
Registration Number6151474
Registration DateTuesday, September 15, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Pseudo MarkAMYOTROPHIC LATERAL SCLEROSIS CLINICAL RESEARCH LEARNING INSTITUTE
Goods and Serviceseducational services, namely, providing seminars, workshops and classes in the field of clinical research and treatments to benefit people with Amyotrophic Lateral Sclerosis (ALS) and/or motor neuron disease
NOT AVAILABLE"LEARNING INSTITUTE"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, January 23, 2020
Primary Code041
First Use Anywhere DateSunday, January 1, 2012
First Use In Commerce DateSunday, January 1, 2012

Trademark Owner History

Party NameNortheast Amyotrophic Lateral Sclerosis Consortium
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPasadena, CA 911051955
Party NameNortheast Amyotrophic Lateral Sclerosis Consortium
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPasadena, CA 911051955
Party NameNortheast Amyotrophic Lateral Sclerosis Consortium
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPasadena, CA 911051955

Trademark Events

Event DateEvent Description
Tuesday, January 21, 2020NEW APPLICATION ENTERED
Thursday, January 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 6, 2020ASSIGNED TO EXAMINER
Wednesday, April 8, 2020NON-FINAL ACTION WRITTEN
Wednesday, April 8, 2020NON-FINAL ACTION E-MAILED
Wednesday, April 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, October 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 15, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 13, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, January 16, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 16, 2026REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 16, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

institute learning research clinical amyotrophic people benefit lateral sclerosis disease neuron motor treatments